New Delhi, March 24 (IANS) On the occasion of World Tuberculosis Day, India announced the world’s first clinical study to scientifically evaluate Ayurveda as an adjunct to standard Anti-Tuberculosis Treatment (ATT), the government said on Tuesday.The collaborative clinical study between the Department of Biotechnology and the Ministry of Ayush will enrol 1,250 newly diagnosed tuberculosis patients across eight institutions to evaluate Ayurveda as an adjunct to standard treatment, focusing on b…
Latest National TB Elimination Programme News & Updates
New Delhi, Feb 13 (IANS) India has fundamentally restructured its public health delivery by integrating AI into a unified strategy, that bridges specialist shortages and scales proactive care, an official statement said on Friday.By deploying AI-enabled tools within the National TB Elimination Programme, the National Diabetic Retinopathy Screening Programme, and the Media Disease Surveillance System, the government has empowered non-specialists to perform high-level screenings, resulting in a 27…
New Delhi, Feb 12 (IANS) Shorter, six‑month and all‑oral treatment regimens for multidrug‑resistant and rifampicin‑resistant tuberculosis (MDR/RR‑TB) are cost‑effective and deliver better health outcomes than longer regimens, an ICMR study said on Thursday.With shorter regimen, “for each additional Quality Adjusted Life Year (QALY) gained, the health system spends Rs 379 less per patient compared to the standard regimen, indicating better health outcomes at lower costs,” said the s…
New Delhi, Jan 12 (IANS) Delhi’s Intermediate Reference Laboratory (IRL), Tuberculosis Centre, has achieved a major milestone with its first certification from the Central Tuberculosis Division (CTD), Government of India, to conduct Drug Susceptibility Testing (DST) for two drugs, an official said on Monday. Bedaquiline (BDQ) and Pretomanid (Pa), which will be tested, are two key drugs used globally for the treatment of drug-resistant tuberculosis (DR-TB), the official said.This certification …